Cour Pharmaceuticals

Cour Pharmaceuticals

Verified
Developing nanoparticle technology to help reset the immune system of multiple sclerosis (MS) patients.

Launch date
Employees
Market cap
-
Net debt
-
Enterprise valuation
$420—630m (Dealroom.co estimates Jan 2024.)
New York City New York (HQ)
Authorizing premium user...